SlideShare a Scribd company logo
11-13.6 WEEKS SCREENING :
NT SCAN & S. BIOCHEMISTRY
FTS : FIRST TRIMESTER SCREENING
PAST, PRESENT AND FUTURE
FAQs
Dr. Nisheeth M. Oza
Dr. Nisheeth M. Oza
M.D., D.G.O., F.C.P.S., D.N.B., (M.N.A.M.S.) (OBGYN)
D.A., M.B.B.S., Dip. YAN
Obstetrician, Gynaecologist, Infertility Consultant,
FMF Certified Ultrasonographer (FMF ID 145907)
Licensed for Aneuploidy Screening NT, NB, DV, Cervix & PIH Screening.
Diploma in Yoga, Ayurveda & Naturopathy
Dr. Oza’s Hospital 87/7, Panvel 410206, Maharashtra India.
Email : drnmozas@gmail.com
Website : drozashospital.com
YouTube : DrOzaConnects
In last 30 years, there have been a lot of developments in FTS,
which have inverted the pyramid of Antenatal Care.
Previously one would only come to know about complications in 3rd
Trimester when pregnant women developed Pre-eclampsia or FGR or
had Preterm Birth or after delivery would know that the Newborn had
Down Syndrome or a major structural abnormality.
Now, instead of waiting helplessly till third trimester, the focus has shifted to
11-13.6 weeks Screening, with the opportunity for prediction, prevention,
early diagnosis & proactive management of such complications of pregnancy.
WHAT TO SCREEN FOR? WHY SCREEN?
1] FOR ANEUPLOIDY e.g. Trisomy 21, 18, 13 :
• Many abort , few have IUFD (Stillbirth).
• Trisomy 18, 13 : Survive only for few hours or days after birth.
• Trisomy 21 : may live upto 49 years, but MR, health problems, financial burden.
2] FOR PRE-ECLAMPSIA & FGR :
• PE – Increased Maternal Mortality, Morbidity.
• FGR- Increases IUFD (Stillbirth), MAS, Neonatal Morbidity.
3] FOR PRETERM BIRTH : Increased Neonatal Mortality, Morbidity.
4] SELECTED CONGENITAL ANOMALIES DETECTABLE AT 11-14 WEEKS :
• Only 10 out of 100.
• Counsel : Compatible with life? Surgery required? Prognosis. Decision making.
DEFINITION OF NT & ITS IMPORTANCE
• Definition : NT is the sonographic appearance of collection of fluid
under the skin behind the neck of the fetus in the First Trimester of
pregnancy.
ITS IMPORTANCE IN SUSPECTING ANEUPLOIDY
Median NT
Normal (Euploid) group 2.0 mm
Trisomy 21 3.4 mm
Trisomy 13 4.0 mm
Trisomy 18 5.5 mm
Turner’s Syndrome 9.2 mm
EVOLUTION OF FTS
• Trisomy 21 Downs Syndrome was first described in 1866 (156 years ago).
• Trisomy 18 (Edward S.) & Trisomy 13(Patau S.) first described in 1960 (62
years ago).
• Association of advanced Maternal Age & Tri 21 first described in 1909.
First the Invasive Tests were introduced for maternal age > 35 yrs.
1970s Amniocentesis (42 Years ago)
1980 CVS
However, 80% of DS were born to mothers < 35 years and it was not possible
to justify so many invasive tests for age more than 35 years.
Therefore, need for Screening tests was felt, so that these can be offered to
all pregnant women in the First Trimester.
Necessity is the mother of invention.
Amongst the SCREENING TESTS available clinically
• 1988 : Triple Marker Test
• 1994 : Double Marker Test
• 2003 : NT Scan Kypros Nicolaides & FMF (work 1992-2002)
• 2005 : Combined Test – NT + Double Marker Test
• 2008 : Quadruple Marker Test
• 2008 : NIPS
EVOLUTION OF NT SCAN, FMF, Courses,
Certification, License
• 1866 – John Langdon Down – Tri 21 – Skin appears to be too large (thick) for their
body.
• 1992 – BMJ – Kypros Nicolaides – excessive accumulation of subcutaneous fluid
behind fetal neck, which could be visualized by ultrasonography as raised NT in
3rd month of pregnancy.
• This was the game changer.
• He founded Fetal Medicine Foundation in UK in 1995. Extensive research by him,
by FMF & multicenter trials between 1992 & 2002 approved his findings & 11 to
13.6 weeks scan became widely used in 2003.
• FMF did standardization of 11-13.6 weeks’ scan.
• FMF runs Online Courses for each of parameter of FTS, conducts exams, does
Certification for each parameter, & has provision of software, licensing & annual
audit & annual renewal of this license under its strict control.
PURPOSE OF THIS SCREENING : AIM & OBJECTIVES
• To screen for Aneuploidy : Trisomy 21, 18, 13.
• To screen for likelihood of developing Pre-eclampsia.
• To screen for likelihood of developing FGR.
• First assessment of the length of Cervix.
• Early detection of certain Structural Anomalies in fetus (10 out of
100).
PRETEST COUNSELING :
• Aneuploidy : Deviation from normal Chromosomal make up, be it in
number or structure.
• Trisomy : Presence of an extra Chromosome at a particular pair of
Chromosomes eg. Trisomy 21, 18, 13.
• What if your fetus has increased NT &/or NB is not visualized?
It means greater risk of Trisomy, structural defect, cardiac defect.
Definitive Diagnostic Invasive Test (CVS) is indicated if NT > 3.0 mm.
• What if your fetus has normal NT value?
Detection Rate of NT Scan for Trisomy 21(DS) is 80%, so you can add Serum
Biochemistry (Double Marker Test) to increase DR of Tri 21 to 90%.
Addition of other Sonographic markers like absent/hypoplastic NB, reversal
of a wave in DV, TR, may further increase DR of Tri 21 to 95%.
• What if Screening (Ute. Art. PI) shows increased risk for developing PE or
FGR?
You may be offered Tab. Aspirin 150 mg/day as Prophylaxis, from day of
screening till 34 or 36 weeks of pregnancy.
• How is the first assessment of length of Cervix on TVS useful?
It serves as baseline for comparing at time of further assessment of length of
Cervix, may be at time of Anomaly Scan (18-22 weeks)or earlier if indicated
by History.
Progressive shortening of length of Cervix or funneling of Cervix or
length < 25 mm on TVS, indicates high risk of Preterm birth/Second
Trimester loss.
So what can be done for that?
1] Cervical Cerclage (Tightening of Os) Operation.
OR
2] Progesterone ( 400 mg vaginally daily at bedtime) till 34 or 36 weeks
of pregnancy.
ASSIGNING PRETEST RISK
Before doing the scan, Data is fed from History, like :
• Mother’s age at the time of delivery.
• Race.
• Number of previous children (Parity).
• Previous Miscarriages.
• Aneuploidy in prior pregnancy & which one?
• History of smoking.
• Maternal Diabetes Mellitus.
• Natural or IVF Conception?
• Chronic HT, SLE, APLA Syndrome.
• Did patient’s mother have Pre-eclampsia?
FROM EXAMINATION :
• Height in cm.
• Current Maternal Weight in Kg.
From this, Pretest Aneuploidy Risk is assigned by the software ie. FMF
Software.
11-13.6 WEEKS SCAN : PARAMETERS INCLUDED
Scan by trained FMF licensed sonographer or by sonographer following
Criteria laid down by FMF :
• CRL : Accurate GA, Dating.
• NT, NB : For Aneuploidy.
• DV (reversed a wave) : Increased chances of Aneuploidy, Cardiac Defects,
fetal Deaths.
• TR : Increased chances of Aneuploidy, Cardiac Defects.
• Ute. Art. PI : Screening for Pre-eclampsia, FGR.
• Cervix Length (TVS) : Subsequent Scan-Shortening- predict PT Del.
• Detectable Anomaly : 10 out of 100.
• DOUBLE MARKER : PAPP-A, Free Beta-hCG.
• DOUBLE MARKER + PlGF : PAPP-A, Free Beta-hCG, PIGF.
DETECTION RATE OF ANEUPLOIDY AND PE
Trisomy 21 DR FPR
Age alone Low
Double Marker Test alone 65% 5%
NT Scan alone (Properly Performed by FMF norms) 80% 5%
NT + Double Marker (Standardized Lab) 90% 5%
NT + Double Marker + NB 93% 5%
NT + Double Marker + NB + DV + TR 95% 3%
Trisomy 18 & 13
NT + Double Marker + NB + DV + TR 75% 5%
PE
Ute. Art. PI (NT Scan) + Double Marker 84% 5%
Ute. Art. PI (NT Scan) + Double Marker + PIGF 93%
POST TEST COUNSELING FOR ANEUPLOIDY
• NT > 3mm or Cystic Hygroma : Increased Chromosomal &/or
Structural abnormality. Therefore, Offer Diagnostic Test : CVS < 14
weeks (or Amniocentesis > 16 weeks).
• NT < 3mm : Add Double Marker Test (Combined Test).
• If Low risk (1 n 1000) – Aneuploidy Unlikely – Reassure.
• If High risk (> 1 in 250) – Means statistical likelihood of Chromosomal
abnormality. Offer Diagnostic Test – CVS/Amniocentesis.
• If Intermediate risk (1 in 250 to 1 in 1000) Counsel – consider NIPS.
NIPS report : Low risk – Reassuring.
High risk – Offer Diagnostic Test – CVS/Amniocentesis.
• NIPS Screening Test, avoids Invasive Test,
Low risk – reassuring ;
High risk – Offer Diagnostic Invasive Test : CVS, rarely false positive.
After Invasive Test, patient may have some bleeding pv, Miscarriage
rate 1 in 300.
NIPS (cf DNA) DR(Sensitivity) (FPR : 0.04%)
Trisomy 21 99%
Trisomy 18 93%
Trisomy 13 99%
POST TEST COUNSELING FOR PRE-ECLAMPSIA & FGR
Low risk – reassure – Routine Antenatal Care.
High risk – Offer Tab. Aspirin 150 mg/day till 34-36 weeks.
POST TEST COUNSELING FOR PRETERM BIRTH
If previous history of Preterm Birth or HSO Insufficient Cervix or Cervix
Length < 25 mm on TVS or Shortening noticed in subsequent scans :
OFFER
1] Cervical Cerclage : Tightening of OS operation. Or
2] Progesterone 400 mg/day vaginally till 36 weeks.
POST TEST COUNSELING FOR STRUCTURAL ANOMALIES
IF ANY DETECTED
• 10 out of 100 are detectable.
Eg. - Anencephaly (Absence of Forebrain)
- Acrania (Absence of Skull)
COUNSELING :
• These two are uniformly lethal, cannot survive after birth.
For other Anomalies :
• Associated Chromosomal abnormalities–confirm by Invasive Test-CVS.
• Brief explanation about the anomaly.
• Its natural course, during pregnancy & after birth.
• Need for surgery after birth.
• Prognosis : Quality of life, Level of disability. Long term Outcome.
• Help in nondirective manner. Help in decision making.
• Management respecting couple’s informed choices.
COST OF VARIOUS SCREENING TESTS IN NAVI MUMBAI TODAY
TEST COST IN INR
NT Scan 2,500/-
Double Marker Test 2,500/-
Double Marker Test + PIGF 3,500/-
NIPS (BASIC) 13,000/-
LABORATORY COST OF DIAGNOSTIC TESTS
CVS 15,000/-
Amniocentesis 15,000/-
FOLLOW UP AFTER DIAGNOSTIC TEST CONFIRMS ANEUPLOIDY
• Non-directive Counseling – Natural history during pregnancy, after
birth.
• Survival after birth.
• Prognosis.
• Informed Decision Making.
FOLLOW UP AFTER INCREASED NT, but NORMAL
KARYOTYPE (CVS)
• Incidence of structural defect in this group is higher.
• Repeat Ultrasound at 15 weeks & Anomaly Scan at 18-22 weeks.
• Fetal 2-D Echo at 22-24 weeks.
FOLLOW UP OF MAJOR STRCTURAL ANOMALY &
CONTINUING PREGNANCY
• Multidisciplinary Team Approach.
• Delivery in Tertiary Care Centre with high quality Neonatal Care
available.
FAQs AFTER FTS : 11-13.6 WEEKS SCREENING
1] NT > 3 mm – Increased chromosomal & structural abnormality – why
not do MTP directly?
• In certain % of cases, NT may resolve after 14 weeks – Normal
Outcome. NT scan is a screening test.
• Diagnostic Test (CVS or Amniocentesis) is important for KT, important
to help parents in decision making & also define recurrence risk.
2] NT > 3 mm & major structural anomaly, why not do MTP directly?
• Diagnostic Test – find out Etiology of Increased NT & calculate
recurrence risk of that condition.
3] FTS is low risk, so is everything fine?
• Congratulations. FTS has shown low risk, which is quite reassuring.
Very very small % of false negative may be there.
Friends, as far as structural anomalies are concerned at this stage, CRL
is only 6 cm & only 10 out of 100 anomalies can be detected at this
stage, so Anomaly Scan at 18-22 weeks is the next step. Some evolving
anomalies can be detected in 3rd trimester/after birth.
4] What will be the Recurrence Risk of Aneuploidy/Structural Anomaly?
• Depends on the Aneuploidy or Structural Anomaly Diagnosed.
5] What is the role of Quadruple Marker Test in Screening?
• It might have some role in those who missed FTS for some reason.
FUTURE OF FTS
1] Will NIPS replace NT Scan (11-13.6 weeks scan)?
• No, NIPS can only predict Aneuploidy risk, NT Scan can do 4 more
things.
2] Will NIPS replace Dual Marker Test?
• Yes it will, as it has higher DR (Sensitivity), When? As soon as the cost
comes down.
3] FUTURE WILL BE ‘SUPPEMENTARY FTS or TESTING’ ie. NT Scan +
NIPS.
Remember 3 things :
1] For FTS, proper Pre Test & Post Test Counseling & following a
protocol are very important.
2] FTS today is NT + Double Marker Test.
3] FTS tomorrow will be NT + NIPS.
THANK YOU

More Related Content

What's hot

usg in first trimester .pptx
usg in first trimester .pptxusg in first trimester .pptx
usg in first trimester .pptx
JiluGeorge8
 
Ultrasound in infertility
Ultrasound in infertilityUltrasound in infertility
Ultrasound in infertilityRupal Shah
 
Role of ultrasound in the Infertility management
Role of ultrasound in the Infertility  management Role of ultrasound in the Infertility  management
Role of ultrasound in the Infertility management
Bharti Gahtori
 
Iugr vld
Iugr vldIugr vld
Iugr vld
Varsha Deshmukh
 
Genetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markersGenetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markers
Mohit Satodia
 
Role of ultrasound in emergency obstetrics dr.shreedhar
Role of ultrasound in emergency obstetrics dr.shreedharRole of ultrasound in emergency obstetrics dr.shreedhar
Role of ultrasound in emergency obstetrics dr.shreedhar
Teleradiology Solutions
 
Abnormal first trimester scan
Abnormal first trimester scanAbnormal first trimester scan
Abnormal first trimester scan
Mahmoud Abdel-Aleem
 
Ultrasonography of the ovary
Ultrasonography of the ovaryUltrasonography of the ovary
Ultrasonography of the ovary
Aboubakr Elnashar
 
Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2drmcbansal
 
Presentation1.pptx, radiological imaging of female infertility.
Presentation1.pptx, radiological imaging of female infertility.Presentation1.pptx, radiological imaging of female infertility.
Presentation1.pptx, radiological imaging of female infertility.Abdellah Nazeer
 
Doppler in pregnancy
Doppler in pregnancyDoppler in pregnancy
Doppler in pregnancy
Bharti Gahtori
 
Focused approach to antenatal care - First trimester screening
Focused approach to antenatal care - First trimester screeningFocused approach to antenatal care - First trimester screening
Focused approach to antenatal care - First trimester screening
Bharti Gahtori
 
Doppler in pregnancy
Doppler in pregnancyDoppler in pregnancy
Doppler in pregnancy
DrAbhishek Gupta
 
Nuchal translucency
Nuchal translucencyNuchal translucency
Nuchal translucency
Vrishit Saraswat
 
1st trimester scan
1st trimester scan1st trimester scan
1st trimester scanobsgynhsnz
 
First trimester ultrasound
First trimester ultrasoundFirst trimester ultrasound
First trimester ultrasound
Roshan Valentine
 
Role of Ultrasound in IVF
Role of  Ultrasound in IVFRole of  Ultrasound in IVF
Role of Ultrasound in IVF
sunitafeme
 
role of Imaging in female infertility
role of Imaging in  female infertilityrole of Imaging in  female infertility
role of Imaging in female infertilitycharusmita chaudhary
 

What's hot (20)

usg in first trimester .pptx
usg in first trimester .pptxusg in first trimester .pptx
usg in first trimester .pptx
 
Nuchal scan
Nuchal scanNuchal scan
Nuchal scan
 
Ultrasound in infertility
Ultrasound in infertilityUltrasound in infertility
Ultrasound in infertility
 
Role of ultrasound in the Infertility management
Role of ultrasound in the Infertility  management Role of ultrasound in the Infertility  management
Role of ultrasound in the Infertility management
 
Iugr vld
Iugr vldIugr vld
Iugr vld
 
Genetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markersGenetic sonogram and soft tissue markers
Genetic sonogram and soft tissue markers
 
Role of ultrasound in emergency obstetrics dr.shreedhar
Role of ultrasound in emergency obstetrics dr.shreedharRole of ultrasound in emergency obstetrics dr.shreedhar
Role of ultrasound in emergency obstetrics dr.shreedhar
 
Abnormal first trimester scan
Abnormal first trimester scanAbnormal first trimester scan
Abnormal first trimester scan
 
Ultrasonography of the ovary
Ultrasonography of the ovaryUltrasonography of the ovary
Ultrasonography of the ovary
 
Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2
 
Presentation1.pptx, radiological imaging of female infertility.
Presentation1.pptx, radiological imaging of female infertility.Presentation1.pptx, radiological imaging of female infertility.
Presentation1.pptx, radiological imaging of female infertility.
 
Doppler in pregnancy
Doppler in pregnancyDoppler in pregnancy
Doppler in pregnancy
 
Ductus venosus
Ductus venosusDuctus venosus
Ductus venosus
 
Focused approach to antenatal care - First trimester screening
Focused approach to antenatal care - First trimester screeningFocused approach to antenatal care - First trimester screening
Focused approach to antenatal care - First trimester screening
 
Doppler in pregnancy
Doppler in pregnancyDoppler in pregnancy
Doppler in pregnancy
 
Nuchal translucency
Nuchal translucencyNuchal translucency
Nuchal translucency
 
1st trimester scan
1st trimester scan1st trimester scan
1st trimester scan
 
First trimester ultrasound
First trimester ultrasoundFirst trimester ultrasound
First trimester ultrasound
 
Role of Ultrasound in IVF
Role of  Ultrasound in IVFRole of  Ultrasound in IVF
Role of Ultrasound in IVF
 
role of Imaging in female infertility
role of Imaging in  female infertilityrole of Imaging in  female infertility
role of Imaging in female infertility
 

Similar to NT SCAN (11-13.6 weeks) & Serum BIOPROFILE

Ultrasonography Scans in Pregnancy
Ultrasonography Scans in PregnancyUltrasonography Scans in Pregnancy
Ultrasonography Scans in Pregnancy
DrNisheethOza
 
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
Lifecare Centre
 
Every fetus at risk
Every fetus at riskEvery fetus at risk
Every fetus at risk
NARENDRA MALHOTRA
 
Screening what tests when
Screening what tests whenScreening what tests when
Screening what tests when
NARENDRA MALHOTRA
 
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.pptANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
9459654457
 
Prenatal diagnosis and fetal therapy
Prenatal diagnosis and fetal therapyPrenatal diagnosis and fetal therapy
Prenatal diagnosis and fetal therapyMohit Satodia
 
Prenatal diagnosis
Prenatal diagnosisPrenatal diagnosis
Prenatal diagnosis
obgymgmcri
 
prenatal genet.pptx
prenatal genet.pptxprenatal genet.pptx
prenatal genet.pptx
krts131j
 
Sridhar prenatal diagnosis
Sridhar prenatal diagnosisSridhar prenatal diagnosis
Sridhar prenatal diagnosisSridhar Mulaka
 
Check point of estimation of gestational age and viability of fetus
Check point of estimation of gestational age and viability of fetusCheck point of estimation of gestational age and viability of fetus
Check point of estimation of gestational age and viability of fetus
muti ullah
 
USG WATCH DOG IN PREGNANCY
USG WATCH DOG IN PREGNANCYUSG WATCH DOG IN PREGNANCY
USG WATCH DOG IN PREGNANCY
NARENDRA MALHOTRA
 
screening for down syndrome
screening for down syndromescreening for down syndrome
screening for down syndrome
Sadaf Khan
 
Early pregnancy ultrasonographic evaluation
Early pregnancy ultrasonographic evaluationEarly pregnancy ultrasonographic evaluation
Early pregnancy ultrasonographic evaluation
Faculty of Medicine - Benha University
 
18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan
DrNisheethOza
 
Kanker ginekologo prof fs
Kanker ginekologo prof fsKanker ginekologo prof fs
Kanker ginekologo prof fs
Devi Syam
 
SCREENING WHAT TESTS WHEN & WHAT NEXT?
SCREENING WHAT TESTS WHEN & WHAT NEXT?SCREENING WHAT TESTS WHEN & WHAT NEXT?
SCREENING WHAT TESTS WHEN & WHAT NEXT?
NARENDRA MALHOTRA
 
PRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptxPRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptx
AnandSGiri
 
Жирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptx
Жирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptxЖирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptx
Жирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptx
Baldandorj Khavalkhaan
 
ClinCon Topic 4.pdf
ClinCon Topic 4.pdfClinCon Topic 4.pdf
ClinCon Topic 4.pdf
AdielCalsa2
 

Similar to NT SCAN (11-13.6 weeks) & Serum BIOPROFILE (20)

Ultrasonography Scans in Pregnancy
Ultrasonography Scans in PregnancyUltrasonography Scans in Pregnancy
Ultrasonography Scans in Pregnancy
 
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
 
Every fetus at risk
Every fetus at riskEvery fetus at risk
Every fetus at risk
 
Screening what tests when
Screening what tests whenScreening what tests when
Screening what tests when
 
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.pptANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
 
Prenatal diagnosis and fetal therapy
Prenatal diagnosis and fetal therapyPrenatal diagnosis and fetal therapy
Prenatal diagnosis and fetal therapy
 
Prenatal diagnosis
Prenatal diagnosisPrenatal diagnosis
Prenatal diagnosis
 
prenatal genet.pptx
prenatal genet.pptxprenatal genet.pptx
prenatal genet.pptx
 
Sridhar prenatal diagnosis
Sridhar prenatal diagnosisSridhar prenatal diagnosis
Sridhar prenatal diagnosis
 
Cnmnpcpsp
CnmnpcpspCnmnpcpsp
Cnmnpcpsp
 
Check point of estimation of gestational age and viability of fetus
Check point of estimation of gestational age and viability of fetusCheck point of estimation of gestational age and viability of fetus
Check point of estimation of gestational age and viability of fetus
 
USG WATCH DOG IN PREGNANCY
USG WATCH DOG IN PREGNANCYUSG WATCH DOG IN PREGNANCY
USG WATCH DOG IN PREGNANCY
 
screening for down syndrome
screening for down syndromescreening for down syndrome
screening for down syndrome
 
Early pregnancy ultrasonographic evaluation
Early pregnancy ultrasonographic evaluationEarly pregnancy ultrasonographic evaluation
Early pregnancy ultrasonographic evaluation
 
18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan
 
Kanker ginekologo prof fs
Kanker ginekologo prof fsKanker ginekologo prof fs
Kanker ginekologo prof fs
 
SCREENING WHAT TESTS WHEN & WHAT NEXT?
SCREENING WHAT TESTS WHEN & WHAT NEXT?SCREENING WHAT TESTS WHEN & WHAT NEXT?
SCREENING WHAT TESTS WHEN & WHAT NEXT?
 
PRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptxPRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptx
 
Жирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptx
Жирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptxЖирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptx
Жирэмсний эрт үеийн хүндрэлийн хэт авиан оношилгоо.pptx
 
ClinCon Topic 4.pdf
ClinCon Topic 4.pdfClinCon Topic 4.pdf
ClinCon Topic 4.pdf
 

Recently uploaded

CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
roti bank
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
ranishasharma67
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
ranishasharma67
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
ranishasharma67
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 

Recently uploaded (20)

CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 

NT SCAN (11-13.6 weeks) & Serum BIOPROFILE

  • 1. 11-13.6 WEEKS SCREENING : NT SCAN & S. BIOCHEMISTRY FTS : FIRST TRIMESTER SCREENING PAST, PRESENT AND FUTURE FAQs Dr. Nisheeth M. Oza
  • 2. Dr. Nisheeth M. Oza M.D., D.G.O., F.C.P.S., D.N.B., (M.N.A.M.S.) (OBGYN) D.A., M.B.B.S., Dip. YAN Obstetrician, Gynaecologist, Infertility Consultant, FMF Certified Ultrasonographer (FMF ID 145907) Licensed for Aneuploidy Screening NT, NB, DV, Cervix & PIH Screening. Diploma in Yoga, Ayurveda & Naturopathy Dr. Oza’s Hospital 87/7, Panvel 410206, Maharashtra India. Email : drnmozas@gmail.com Website : drozashospital.com YouTube : DrOzaConnects
  • 3. In last 30 years, there have been a lot of developments in FTS, which have inverted the pyramid of Antenatal Care. Previously one would only come to know about complications in 3rd Trimester when pregnant women developed Pre-eclampsia or FGR or had Preterm Birth or after delivery would know that the Newborn had Down Syndrome or a major structural abnormality.
  • 4. Now, instead of waiting helplessly till third trimester, the focus has shifted to 11-13.6 weeks Screening, with the opportunity for prediction, prevention, early diagnosis & proactive management of such complications of pregnancy.
  • 5. WHAT TO SCREEN FOR? WHY SCREEN? 1] FOR ANEUPLOIDY e.g. Trisomy 21, 18, 13 : • Many abort , few have IUFD (Stillbirth). • Trisomy 18, 13 : Survive only for few hours or days after birth. • Trisomy 21 : may live upto 49 years, but MR, health problems, financial burden. 2] FOR PRE-ECLAMPSIA & FGR : • PE – Increased Maternal Mortality, Morbidity. • FGR- Increases IUFD (Stillbirth), MAS, Neonatal Morbidity. 3] FOR PRETERM BIRTH : Increased Neonatal Mortality, Morbidity. 4] SELECTED CONGENITAL ANOMALIES DETECTABLE AT 11-14 WEEKS : • Only 10 out of 100. • Counsel : Compatible with life? Surgery required? Prognosis. Decision making.
  • 6. DEFINITION OF NT & ITS IMPORTANCE • Definition : NT is the sonographic appearance of collection of fluid under the skin behind the neck of the fetus in the First Trimester of pregnancy. ITS IMPORTANCE IN SUSPECTING ANEUPLOIDY Median NT Normal (Euploid) group 2.0 mm Trisomy 21 3.4 mm Trisomy 13 4.0 mm Trisomy 18 5.5 mm Turner’s Syndrome 9.2 mm
  • 7. EVOLUTION OF FTS • Trisomy 21 Downs Syndrome was first described in 1866 (156 years ago). • Trisomy 18 (Edward S.) & Trisomy 13(Patau S.) first described in 1960 (62 years ago). • Association of advanced Maternal Age & Tri 21 first described in 1909. First the Invasive Tests were introduced for maternal age > 35 yrs. 1970s Amniocentesis (42 Years ago) 1980 CVS However, 80% of DS were born to mothers < 35 years and it was not possible to justify so many invasive tests for age more than 35 years. Therefore, need for Screening tests was felt, so that these can be offered to all pregnant women in the First Trimester. Necessity is the mother of invention.
  • 8. Amongst the SCREENING TESTS available clinically • 1988 : Triple Marker Test • 1994 : Double Marker Test • 2003 : NT Scan Kypros Nicolaides & FMF (work 1992-2002) • 2005 : Combined Test – NT + Double Marker Test • 2008 : Quadruple Marker Test • 2008 : NIPS
  • 9. EVOLUTION OF NT SCAN, FMF, Courses, Certification, License • 1866 – John Langdon Down – Tri 21 – Skin appears to be too large (thick) for their body. • 1992 – BMJ – Kypros Nicolaides – excessive accumulation of subcutaneous fluid behind fetal neck, which could be visualized by ultrasonography as raised NT in 3rd month of pregnancy. • This was the game changer. • He founded Fetal Medicine Foundation in UK in 1995. Extensive research by him, by FMF & multicenter trials between 1992 & 2002 approved his findings & 11 to 13.6 weeks scan became widely used in 2003. • FMF did standardization of 11-13.6 weeks’ scan. • FMF runs Online Courses for each of parameter of FTS, conducts exams, does Certification for each parameter, & has provision of software, licensing & annual audit & annual renewal of this license under its strict control.
  • 10. PURPOSE OF THIS SCREENING : AIM & OBJECTIVES • To screen for Aneuploidy : Trisomy 21, 18, 13. • To screen for likelihood of developing Pre-eclampsia. • To screen for likelihood of developing FGR. • First assessment of the length of Cervix. • Early detection of certain Structural Anomalies in fetus (10 out of 100).
  • 11. PRETEST COUNSELING : • Aneuploidy : Deviation from normal Chromosomal make up, be it in number or structure. • Trisomy : Presence of an extra Chromosome at a particular pair of Chromosomes eg. Trisomy 21, 18, 13. • What if your fetus has increased NT &/or NB is not visualized? It means greater risk of Trisomy, structural defect, cardiac defect. Definitive Diagnostic Invasive Test (CVS) is indicated if NT > 3.0 mm.
  • 12. • What if your fetus has normal NT value? Detection Rate of NT Scan for Trisomy 21(DS) is 80%, so you can add Serum Biochemistry (Double Marker Test) to increase DR of Tri 21 to 90%. Addition of other Sonographic markers like absent/hypoplastic NB, reversal of a wave in DV, TR, may further increase DR of Tri 21 to 95%. • What if Screening (Ute. Art. PI) shows increased risk for developing PE or FGR? You may be offered Tab. Aspirin 150 mg/day as Prophylaxis, from day of screening till 34 or 36 weeks of pregnancy. • How is the first assessment of length of Cervix on TVS useful? It serves as baseline for comparing at time of further assessment of length of Cervix, may be at time of Anomaly Scan (18-22 weeks)or earlier if indicated by History.
  • 13. Progressive shortening of length of Cervix or funneling of Cervix or length < 25 mm on TVS, indicates high risk of Preterm birth/Second Trimester loss. So what can be done for that? 1] Cervical Cerclage (Tightening of Os) Operation. OR 2] Progesterone ( 400 mg vaginally daily at bedtime) till 34 or 36 weeks of pregnancy.
  • 14. ASSIGNING PRETEST RISK Before doing the scan, Data is fed from History, like : • Mother’s age at the time of delivery. • Race. • Number of previous children (Parity). • Previous Miscarriages. • Aneuploidy in prior pregnancy & which one? • History of smoking. • Maternal Diabetes Mellitus. • Natural or IVF Conception? • Chronic HT, SLE, APLA Syndrome. • Did patient’s mother have Pre-eclampsia?
  • 15. FROM EXAMINATION : • Height in cm. • Current Maternal Weight in Kg. From this, Pretest Aneuploidy Risk is assigned by the software ie. FMF Software.
  • 16. 11-13.6 WEEKS SCAN : PARAMETERS INCLUDED Scan by trained FMF licensed sonographer or by sonographer following Criteria laid down by FMF : • CRL : Accurate GA, Dating. • NT, NB : For Aneuploidy. • DV (reversed a wave) : Increased chances of Aneuploidy, Cardiac Defects, fetal Deaths. • TR : Increased chances of Aneuploidy, Cardiac Defects. • Ute. Art. PI : Screening for Pre-eclampsia, FGR. • Cervix Length (TVS) : Subsequent Scan-Shortening- predict PT Del. • Detectable Anomaly : 10 out of 100. • DOUBLE MARKER : PAPP-A, Free Beta-hCG. • DOUBLE MARKER + PlGF : PAPP-A, Free Beta-hCG, PIGF.
  • 17. DETECTION RATE OF ANEUPLOIDY AND PE Trisomy 21 DR FPR Age alone Low Double Marker Test alone 65% 5% NT Scan alone (Properly Performed by FMF norms) 80% 5% NT + Double Marker (Standardized Lab) 90% 5% NT + Double Marker + NB 93% 5% NT + Double Marker + NB + DV + TR 95% 3% Trisomy 18 & 13 NT + Double Marker + NB + DV + TR 75% 5% PE Ute. Art. PI (NT Scan) + Double Marker 84% 5% Ute. Art. PI (NT Scan) + Double Marker + PIGF 93%
  • 18. POST TEST COUNSELING FOR ANEUPLOIDY • NT > 3mm or Cystic Hygroma : Increased Chromosomal &/or Structural abnormality. Therefore, Offer Diagnostic Test : CVS < 14 weeks (or Amniocentesis > 16 weeks). • NT < 3mm : Add Double Marker Test (Combined Test). • If Low risk (1 n 1000) – Aneuploidy Unlikely – Reassure. • If High risk (> 1 in 250) – Means statistical likelihood of Chromosomal abnormality. Offer Diagnostic Test – CVS/Amniocentesis. • If Intermediate risk (1 in 250 to 1 in 1000) Counsel – consider NIPS. NIPS report : Low risk – Reassuring. High risk – Offer Diagnostic Test – CVS/Amniocentesis.
  • 19. • NIPS Screening Test, avoids Invasive Test, Low risk – reassuring ; High risk – Offer Diagnostic Invasive Test : CVS, rarely false positive. After Invasive Test, patient may have some bleeding pv, Miscarriage rate 1 in 300. NIPS (cf DNA) DR(Sensitivity) (FPR : 0.04%) Trisomy 21 99% Trisomy 18 93% Trisomy 13 99%
  • 20. POST TEST COUNSELING FOR PRE-ECLAMPSIA & FGR Low risk – reassure – Routine Antenatal Care. High risk – Offer Tab. Aspirin 150 mg/day till 34-36 weeks. POST TEST COUNSELING FOR PRETERM BIRTH If previous history of Preterm Birth or HSO Insufficient Cervix or Cervix Length < 25 mm on TVS or Shortening noticed in subsequent scans : OFFER 1] Cervical Cerclage : Tightening of OS operation. Or 2] Progesterone 400 mg/day vaginally till 36 weeks.
  • 21. POST TEST COUNSELING FOR STRUCTURAL ANOMALIES IF ANY DETECTED • 10 out of 100 are detectable. Eg. - Anencephaly (Absence of Forebrain) - Acrania (Absence of Skull) COUNSELING : • These two are uniformly lethal, cannot survive after birth.
  • 22. For other Anomalies : • Associated Chromosomal abnormalities–confirm by Invasive Test-CVS. • Brief explanation about the anomaly. • Its natural course, during pregnancy & after birth. • Need for surgery after birth. • Prognosis : Quality of life, Level of disability. Long term Outcome. • Help in nondirective manner. Help in decision making. • Management respecting couple’s informed choices.
  • 23. COST OF VARIOUS SCREENING TESTS IN NAVI MUMBAI TODAY TEST COST IN INR NT Scan 2,500/- Double Marker Test 2,500/- Double Marker Test + PIGF 3,500/- NIPS (BASIC) 13,000/- LABORATORY COST OF DIAGNOSTIC TESTS CVS 15,000/- Amniocentesis 15,000/-
  • 24. FOLLOW UP AFTER DIAGNOSTIC TEST CONFIRMS ANEUPLOIDY • Non-directive Counseling – Natural history during pregnancy, after birth. • Survival after birth. • Prognosis. • Informed Decision Making.
  • 25. FOLLOW UP AFTER INCREASED NT, but NORMAL KARYOTYPE (CVS) • Incidence of structural defect in this group is higher. • Repeat Ultrasound at 15 weeks & Anomaly Scan at 18-22 weeks. • Fetal 2-D Echo at 22-24 weeks. FOLLOW UP OF MAJOR STRCTURAL ANOMALY & CONTINUING PREGNANCY • Multidisciplinary Team Approach. • Delivery in Tertiary Care Centre with high quality Neonatal Care available.
  • 26. FAQs AFTER FTS : 11-13.6 WEEKS SCREENING 1] NT > 3 mm – Increased chromosomal & structural abnormality – why not do MTP directly? • In certain % of cases, NT may resolve after 14 weeks – Normal Outcome. NT scan is a screening test. • Diagnostic Test (CVS or Amniocentesis) is important for KT, important to help parents in decision making & also define recurrence risk. 2] NT > 3 mm & major structural anomaly, why not do MTP directly? • Diagnostic Test – find out Etiology of Increased NT & calculate recurrence risk of that condition.
  • 27. 3] FTS is low risk, so is everything fine? • Congratulations. FTS has shown low risk, which is quite reassuring. Very very small % of false negative may be there. Friends, as far as structural anomalies are concerned at this stage, CRL is only 6 cm & only 10 out of 100 anomalies can be detected at this stage, so Anomaly Scan at 18-22 weeks is the next step. Some evolving anomalies can be detected in 3rd trimester/after birth. 4] What will be the Recurrence Risk of Aneuploidy/Structural Anomaly? • Depends on the Aneuploidy or Structural Anomaly Diagnosed. 5] What is the role of Quadruple Marker Test in Screening? • It might have some role in those who missed FTS for some reason.
  • 28. FUTURE OF FTS 1] Will NIPS replace NT Scan (11-13.6 weeks scan)? • No, NIPS can only predict Aneuploidy risk, NT Scan can do 4 more things. 2] Will NIPS replace Dual Marker Test? • Yes it will, as it has higher DR (Sensitivity), When? As soon as the cost comes down. 3] FUTURE WILL BE ‘SUPPEMENTARY FTS or TESTING’ ie. NT Scan + NIPS.
  • 29. Remember 3 things : 1] For FTS, proper Pre Test & Post Test Counseling & following a protocol are very important. 2] FTS today is NT + Double Marker Test. 3] FTS tomorrow will be NT + NIPS.